Determined to drive change in immuno-oncology
At Phio Pharmaceuticals, our mission is to develop innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against cancer without genetic modification.
We are dedicated to maximizing the value of our INTASYL™ self-delivering technology for immuno-oncology.
Our INTASYL™ self-delivering RNA inference (RNAi) technology activates immune cells to better recognize and kill cancer cells. It does so by silencing genes and reducing the expression of proteins that tumors use to escape the immune response.
If you share our determination to look beyond established treatments and to achieve outcomes that were once out of reach, join us. You can learn more about joining the Phio team by contacting email@example.com or by visiting us on LinkedIn to see our current employment opportunities. Or, click below to learn more about us and our team.
Get in touch with us.